I'm also noticing a pattern in how ONCS delivers news. They never put out a press release pointing investors to a conference where data might be presented. They always issue a press release after the conference where either Heller or Daud presents data. See the following:
Heller--10/8/2013--presented data for the combination trial involving anti-PD1 at Old Dominiun University. Data was presented at the Cancer Vaccines & Gene Therapy Conference. No press release before, press release day after.
Daud--12/16/2013--presented interim melanoma data at the Advanced Cancer Immunotherapy Conference. No press release before, press release day after.
Heller--5/22/2014--will present data for both phase 1 & 2 at ASGOT--we have harped on IR to release a press release--they have refused--I bet they won't do one. We will have a press release the next day for the phase 1 and 2 final data.
Daud--4/6/2014--will present at AACR--no press release before event--we will get a press release the next day. Title is "Novel Immune and Targeted Therapies for Hematologic Malignancies and Solid Tumors"--ONCS does this, its Merck, etc.
Basically, if ONCS issues a press release about an upcoming conference, there will be nothing substantive. However, if one of these guys is presenting, expect good things. I Might be totally wrong and, if I am, so be it. However, that is why I'm excited.
News 
Market Data 
Discover 
